Demarsico R Md & Degrande G C is categorized under Gynecologists and OB GYNs in Montclair, NJ and active since 1977.
Demarsico R Md & Degrande G C was established in 1977, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Gynecologists and OB GYNs business, which does work in the B2C market, and is classified as a Gynecologists and OB GYNs, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Dr Richard Demarsico at the company’s single location by writing to 33 North Fullerton Avenue, Montclair, New Jersey NJ 07042 or by phoning (973) 744-2226. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Demarsico R Md & Degrande G C |
Contact Person: | Dr Richard Demarsico |
Address: | 33 North Fullerton Avenue, Montclair, New Jersey 07042 |
Phone Number: | (973) 744-2226 |
Annual Revenue (USD): | $500.000 to $999.999 |
Founded: | 1977 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Gynecologists and OB GYNs |
SIC Code: | 8011 |
NAICS Code: | 621111 |
Share This Business: |
Demarsico R Md & Degrande G C was started in 1977 to provide professional Gynecologists and OB GYNs under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Dr Richard Demarsico for inquiries that concern Demarsico R Md & Degrande G C by calling the company number (973) 744-2226, as your correspondence is most welcome. Additionally, the physical location of the single location of Demarsico R Md & Degrande G C can be found at the coordinates 40.815247,-74.216396 as well as the street address 33 North Fullerton Avenue in Montclair, New Jersey 07042.
For its online presence, you may visit Demarsico R Md & Degrande G C’s website at and engage with its social media outlets through on Twitter and on Facebook.